At age twelve, I watched my grandmother lose her three year battle with lung cancer. Her battle and my family’s support showed me that while cancer is personal, it takes a village to fight it.
We know that one size does not fit all when it comes to treating cancer, but where do we go from here?
This World Cancer Day, we’re looking at how pharmacogenomics can improve the treatment options available to cancer patients around the world
Pharmacogenomics is an industry buzzword right now —and for good reason. It’s changing the way we think about healthcare, from the way we recruit patients for studies to the way we monitor a patient’s response to an already marketed drug.
Oncology patients and products need and deserve specialized care, and that’s best accomplished through a comprehensive service model. UBC’s customized, 360° solution combines expert reimbursement services, an industry-leading Patient Assistance Program model, and compassionate nursing support.
UBC works with life science companies to help them develop a drug, take it through commercialization, and demonstrate its post-launch value and safety.
UBC's worldwide experience and flexible resource capacity management approach recently helped us complete enrollment for one manufacturer’s study nearly four months ahead of schedule. Our recent blog post delves into the details.
The development of innovative therapies calls for innovative teams with clinical expertise, a passion for patient care and the vision to create medicine that has the potential to positively affect patient populations of one to one million. For these reasons, UBC welcomes Don Gabriel , MD, PhD, to our Global Clinical Development & Operations team.
Nutrition management plays a vital role in influencing the course of treatment, outcomes, and overall quality of life for patients with cancer, yet 80% of cancer patients never receive nutrition support or interact with a registered dietitian. In fact, approximately 1 in 5 cancer deaths in the U.S. are related to malnutrition and severe weight loss.
Accredo’s Oncology Nutrition Service program provides patient-driven, clinician-supported nutritional services, including TherapEase Cuisine, an online self-service tool to guide patients’ diet and nutrition decisions throughout their treatment.
A study, designed and undertaken by medical and industry experts including Krista Payne and Noreen Lordan of UBC, assesses the health-related quality of life (HRQoL) of 154 patients with multiple myeloma (MM). This cross-sectional, bi-national, multicenter study enrolled patients with MM presenting for routine care visits at five United Kingdom and six German sites.